Connect with us

Press Release

BRKT passes will be issued on the Seychelles Stock Exchange LOEX on April 28

Published

on

It is reported that Warren Buffett’s core strategist team has decided to launch the BRKT certificate experiment to replicate Berkshire Hathaway’s 47573 times earnings in the era of equity economy in the field of digital asset investment.

BRKT fund’s tweet said: Warren Buffett’s core strategist team decided to launch the BRKT token experiment, and Berkshire token foundation was responsible for the overall implementation of the token experiment plan. BRKT Berkshire Hathaway pass plans to conduct no more than 10 periods of digital asset token donation experiments. Each period of donated digital asset will have a new token corresponding to the donation experiment. The usdt donors in each period of digital asset token donation will receive BRKT’s airdrop to the donation address after the last period of token donation experiment. BRKT will never lock up and will be in circulation. BRKT pass will be the only token of Berkshire Hathaway digital assets, enjoying the ownership of investment income of the whole BRKT ecology and the voting right of ecological governance.

The total number of experiments donated by BRKT is 300 million, and the original financial model design is based on the concept of real distributed autonomous community. It is the only great financial experiment in the world led by the elite to lead the prophet to land and practice the core concept of distributed finance.

The BRKT donation trial has started. After 12 months of trial, the first batch of BRKT passes will be issued on the Seychelles Stock Exchange LOEX on April 28( www.loex.io )for open trading.

##WDWIRE NEWS DISCLAIMER##

This news has been published for the above source. If you purchase any items using the product and services mentioned in the link, read and accept the terms at your own risk. — Content creator did not involve the WDWIRE news desk in the creation or image in this content. — WDWIRE and its distribution partners are not directly or indirectly responsible for any claims made in the above statements. — Contact the vendor of the product directly. — WDWIRE and its distribution partners are not responsible for news ranking or SEO of news and its rankings. Ultimately, it is always the final decision of distribution partners and how it indexes on search engines and distribution sites. — WDWIRE and its distribution partners have no control over and cannot change any ranking factors. Further reproduction or distribution beyond the intended recipient is prohibited without the Owner’s prior written consent. Including this disclosure.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Precision Telemed Welcomes Pharmacist Danny Postell, PharmD, to Its Ownership Group

Published

on

With more than 20 years behind the pharmacy counter, Dr. Postell joins the Precision Telemed team to help guide compliance, quality, and patient safety across the company’s GLP-1 weight loss and hormone optimization programs.

United States, 1st May 2026 — Precision Telemed, the family-owned, doctor-led telemedicine platform known for its work in personalized weight loss, hormone therapy, and longevity care, is excited to welcome Danny Postell, PharmD, to its ownership group. A practicing pharmacist and longtime pharmacy owner, Dr. Postell joins the team at a moment when telehealth and compounded medications are evolving faster than ever, and when patients are asking more questions than ever about safety, quality, and the people behind their care.

His arrival marks a meaningful moment for the company. As a graduate of the University of Georgia College of Pharmacy and the owner of multiple pharmacies including Huff’s Pharmacy in Georgia, Dr. Postell brings the kind of experience you can only get by spending two decades behind the counter: filling prescriptions, talking to patients, working with physicians, and watching the industry change firsthand. That perspective, leadership at Precision Telemed says, is exactly what the company wanted to add at this stage of its growth.

“What drew me to Precision Telemed is how seriously they take patient care,” said Dr. Postell. “Telehealth has changed a lot of lives, but it only works when the clinical side and the pharmacy side are both rock solid. I’m looking forward to helping the team keep that bar high.”

A Pharmacist’s Eye on Patient Care

Anyone who’s spent time in an independent pharmacy knows the work is personal. You learn names. You notice when something’s off. You watch patients try medications, change doses, get better, hit setbacks, and start again. Dr. Postell has spent his career in that environment, and it’s shaped how he thinks about safety, compounding, and what good care actually looks like in practice.

In his role with Precision Telemed, he’ll work closely with the leadership team and the company’s pharmacy partners on the things that matter most behind the scenes: quality assurance, regulatory compliance, and keeping a close eye on FDA and state board guidance as it evolves. The goal isn’t just to meet today’s standards. It’s to stay ahead of where the industry is heading next.

Supporting the Programs Patients Rely On

Precision Telemed builds personalized treatment plans that pair clinician oversight with medications dispensed by trusted U.S. compounding pharmacies operating under 503A and 503B regulatory frameworks. Dr. Postell’s experience will support the company’s most-requested programs, including compounded semaglutide for medically guided weight management, compounded tirzepatide for patients exploring dual incretin therapy, and the microdose GLP-1 protocol for those who prefer a gentler, lower-dose approach to metabolic health.

“Danny is the kind of person you want in the room when big decisions are being made,” said Carlie Cannon-Rius, Owner and CEO of Precision Telemed. “He’s a pharmacist first, an owner second, and a problem-solver always. Having him in our ownership group means we get that lens on every decision, especially when it comes to safety and compliance. That’s exactly the partnership we wanted to build.”

Patients curious about Precision Telemed’s programs can head over to precisiontelemed.com to explore the available treatments, book a virtual consultation with a licensed provider, and learn more about how the team approaches care.

About Precision Telemed

Precision Telemed is a family-owned, doctor-led telemedicine company offering personalized care across weight loss, hormone optimization, and longevity. Patients work with licensed providers entirely online, receive pharmaceutical-grade compounded medications from trusted U.S. pharmacies, and get free customized nutrition and workout programs along the way. Pricing is transparent and all-inclusive, with no surprise fees. Learn more at precisiontelemed.com or visit the About Us page to read more about the team and the company’s approach.

Media Contact

Precision Telemed

3030 N Rocky Point Drive W, Suite 150 Tampa, FL 33607

Email: info@precisiontelemed.com Call: (877) 745-4115

Text: (877) 745-4115

Website: https://precisiontelemed.com/contact-us/
 

Disclaimer

Precision Telemed offers only compounded medications, which are made in State Board of Pharmacy licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. These facilities are strictly regulated. The products themselves are not FDA-approved due to the provider’s prescriptions being customized to the patient’s needs. Compounded medications differ from FDA-approved products in factors such as strength, dose, and route of administration, which makes direct comparison to FDA-approved products difficult. All compounded drugs prescribed are based on a licensed healthcare provider’s medical judgment from a telehealth encounter that includes medical history.

Precision Health Digital LLC is a patient management platform that works with Doctors Now PC, a group of independent physicians and practitioners. Precision Telemed does not provide medical services, and payment does not guarantee the writing of a prescription. Doctors Now PC provides medical services using the Precision Health Digital platform. The information in this release is for informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment.

Media Contact

Organization: Precision Telemed

Contact Person: Support team

Website: https://precisiontelemed.com

Email: Send Email

Address:3030 N Rocky Point Drive W, Suite 150 Tampa, FL 33607

Country:United States

Release id:44577

The post Precision Telemed Welcomes Pharmacist Danny Postell, PharmD, to Its Ownership Group appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Precision Telemed Welcomes Pharmacist Danny Postell, PharmD, to Its Ownership Group

Published

on

With more than 20 years behind the pharmacy counter, Dr. Postell joins the Precision Telemed team to help guide compliance, quality, and patient safety across the company’s GLP-1 weight loss and hormone optimization programs.

United States, 1st May 2026 — Precision Telemed, the family-owned, doctor-led telemedicine platform known for its work in personalized weight loss, hormone therapy, and longevity care, is excited to welcome Danny Postell, PharmD, to its ownership group. A practicing pharmacist and longtime pharmacy owner, Dr. Postell joins the team at a moment when telehealth and compounded medications are evolving faster than ever, and when patients are asking more questions than ever about safety, quality, and the people behind their care.

His arrival marks a meaningful moment for the company. As a graduate of the University of Georgia College of Pharmacy and the owner of multiple pharmacies including Huff’s Pharmacy in Georgia, Dr. Postell brings the kind of experience you can only get by spending two decades behind the counter: filling prescriptions, talking to patients, working with physicians, and watching the industry change firsthand. That perspective, leadership at Precision Telemed says, is exactly what the company wanted to add at this stage of its growth.

“What drew me to Precision Telemed is how seriously they take patient care,” said Dr. Postell. “Telehealth has changed a lot of lives, but it only works when the clinical side and the pharmacy side are both rock solid. I’m looking forward to helping the team keep that bar high.”

A Pharmacist’s Eye on Patient Care

Anyone who’s spent time in an independent pharmacy knows the work is personal. You learn names. You notice when something’s off. You watch patients try medications, change doses, get better, hit setbacks, and start again. Dr. Postell has spent his career in that environment, and it’s shaped how he thinks about safety, compounding, and what good care actually looks like in practice.

In his role with Precision Telemed, he’ll work closely with the leadership team and the company’s pharmacy partners on the things that matter most behind the scenes: quality assurance, regulatory compliance, and keeping a close eye on FDA and state board guidance as it evolves. The goal isn’t just to meet today’s standards. It’s to stay ahead of where the industry is heading next.

Supporting the Programs Patients Rely On

Precision Telemed builds personalized treatment plans that pair clinician oversight with medications dispensed by trusted U.S. compounding pharmacies operating under 503A and 503B regulatory frameworks. Dr. Postell’s experience will support the company’s most-requested programs, including compounded semaglutide for medically guided weight management, compounded tirzepatide for patients exploring dual incretin therapy, and the microdose GLP-1 protocol for those who prefer a gentler, lower-dose approach to metabolic health.

“Danny is the kind of person you want in the room when big decisions are being made,” said Carlie Cannon-Rius, Owner and CEO of Precision Telemed. “He’s a pharmacist first, an owner second, and a problem-solver always. Having him in our ownership group means we get that lens on every decision, especially when it comes to safety and compliance. That’s exactly the partnership we wanted to build.”

Patients curious about Precision Telemed’s programs can head over to precisiontelemed.com to explore the available treatments, book a virtual consultation with a licensed provider, and learn more about how the team approaches care.

About Precision Telemed

Precision Telemed is a family-owned, doctor-led telemedicine company offering personalized care across weight loss, hormone optimization, and longevity. Patients work with licensed providers entirely online, receive pharmaceutical-grade compounded medications from trusted U.S. pharmacies, and get free customized nutrition and workout programs along the way. Pricing is transparent and all-inclusive, with no surprise fees. Learn more at precisiontelemed.com or visit the About Us page to read more about the team and the company’s approach.

Media Contact

Precision Telemed

3030 N Rocky Point Drive W, Suite 150 Tampa, FL 33607

Email: info@precisiontelemed.com Call: (877) 745-4115

Text: (877) 745-4115

Website: https://precisiontelemed.com/contact-us/
 

Disclaimer

Precision Telemed offers only compounded medications, which are made in State Board of Pharmacy licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. These facilities are strictly regulated. The products themselves are not FDA-approved due to the provider’s prescriptions being customized to the patient’s needs. Compounded medications differ from FDA-approved products in factors such as strength, dose, and route of administration, which makes direct comparison to FDA-approved products difficult. All compounded drugs prescribed are based on a licensed healthcare provider’s medical judgment from a telehealth encounter that includes medical history.

Precision Health Digital LLC is a patient management platform that works with Doctors Now PC, a group of independent physicians and practitioners. Precision Telemed does not provide medical services, and payment does not guarantee the writing of a prescription. Doctors Now PC provides medical services using the Precision Health Digital platform. The information in this release is for informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment.

Media Contact

Organization: Precision Telemed

Contact Person: Support team

Website: https://precisiontelemed.com

Email: Send Email

Address:3030 N Rocky Point Drive W, Suite 150 Tampa, FL 33607

Country:United States

Release id:44577

The post Precision Telemed Welcomes Pharmacist Danny Postell, PharmD, to Its Ownership Group appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Representatives from More Than 40 Countries Discuss New Models of Global Growth in Moscow

Published

on

Moscow, Russia – 01/05/2026 – (SeaPRwire) – The 2nd Open Dialogue “The Future of the World: A New Platform for Global Growth” took place in Russia, bringing together experts and young researchers from more than 40 countries who proposed ideas on the development of the economy, technology, education, and the environment. The key unifying principle of the event was a focus on people, international cooperation, and the search for new models of global growth through dialogue and the practical implementation of ideas. The large-scale three-day program at the Russia National Centre has concluded, combining expert discussions, presentations by authors of the best essays from around the world, and informal communication with experts.

According to the official remarks, the Open Dialogue has achieved a global footprint that covers the entire planet.

“Experts, business leaders, and researchers from 120 countries took part in the essay and creative works competition, including representatives from Asia, Africa, the Middle East, Europe, Australia, North and South America. All authors and researchers, with diverse experiences and perspectives, were united by a strong and bold idea: to form a shared understanding of the future — the future of a world entering an era of profound structural change. It is evident that no country can develop in isolation, at the expense of other states or to their detriment. Furthermore, modern global challenges require a joint response and collective efforts. This means that the model of global development will be sustainable and fair only if it is based on the principles of equality and mutual respect, and takes into account the interests of all countries,” the honorary guest of the event stated.

According to the Russian leader, a multipolar architecture of global development is being formed before our eyes. Within it, an important role is played by states that understand and value national sovereignty.

The results of the large-scale event were summarized by Russian economist Maxim Oreshkin: “Russia, in a number of areas, is an advanced country in terms of the development of digital platform solutions. Our approach is one of joint development. When Russian digital platforms enter other countries’ markets, they bring data localization, local partner involvement, training for local personnel, and the development of their own competencies in platform solution development. Russia comes to develop together, not to collect colonial rent from countries that lack access to technological solutions. We are in favor of developing together.”

Maxim Oreshkin noted that the reach of the Open Dialogue will continue to grow each year. According to him, significant attention is being paid to the stage of implementing the ideas proposed in the essays. A mentorship format has been introduced — Russian businesses and international companies are beginning to work with essayists, involve them in their projects, and help bring their ideas to life.

At the 2nd Open Dialogue, the best essay authors were identified in four areas: “Investing in People,” “Investing in Connectivity,” “Investing in Technology,” and “Investing in the Environment.”

The winner in the “Investing in Technology” track was Aya Arfaoui, a student of Mohammed V University in Rabat, Morocco. She raised the issue of the digital sovereignty of developing countries. According to her, international institutions do not provide sufficient influence in regulating the digital space.

Solomon Gardie, a postgraduate student at Addis Ababa University in Ethiopia, became the winner in the “Investing in Connectivity” track. His essay focused on connectivity and the mobility of sovereign data. He proposed a system in which data is processed and anonymized before cross-border transfer, and only in this form can it be used for the common good. He also noted that, within cooperation in the BRICS+ framework, one of the first areas could be healthcare, particularly epidemiological monitoring and disease control.

In the “Investing in the Environment” track, the winner was Soumya Bhowmick, a research fellow at the Observer Research Foundation (India). In his presentation, he stated that for almost 100 years, the world has focused on measuring GDP, which does not reflect a country’s real wealth.

The winner of the “Investing in People” track was Lubinda Haabazoka from Zambia. In his speech, he noted that for real convergence among countries of the Global South, not only declarations of multipolarity are needed, but also practical changes in key systems of interaction — primarily in education, which directly affects opportunities for cooperation and knowledge exchange.

The future should be built around the individual, their health, agency, and a long, meaningful life, rather than around technologies and outdated systems, believes Dr. Selina Neri, co-founder, CEO, and dean of Future Readiness Academy (UAE), and an expert of the 2nd Open Dialogue in the “Investing in People” track. According to her, this requires new approaches to education, work, and technology development that focus on human flourishing, sovereignty, and the practical implementation of ideas rather than copying ineffective models.

More than 1,600 authors from all continents submitted their works to participate in the 2nd Open Dialogue. Seventy-five essay authors hold academic degrees. The conclusions drawn from the discussions will be reviewed at the St. Petersburg International Economic Forum and will be reflected in its business program. Essayists and experts will also be engaged in activities within the BRICS platform and involved in preparations for the Russia–Africa Summit.

Social Links

Telegram: https://t.me/gowithRussia

Media Contacts

Brand: Russia National Centre

Contact: Media team

Email: pressa@russia.ru

Website: https://en.russia.ru 

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST